Upcoming catalysts and material SEC filings for Neumora Therapeutics, Inc. (NMRA). 1 upcoming catalyst.
Trial readout (estimated)
Q3 2026 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 15d ago